Merck & Co co-led the round, which will help the health data software producer to further develop its AI-powered clinical data repository.
US-based healthcare data technology provider Ciox Health has raised $30m in a funding round co-led by pharmaceutical firm Merck & Co’s Global Health Innovation (GHI) Fund and investment firm New Mountain Capital.
Founded in 1976, Ciox Health has developed an artificial intelligence-powered platform that is used to extract and access data from disparate health records.
The technology is used by healthcare providers, law firms, life science companies, life insurers and patients to track, view, download, store and verify the status…
